Navigation Links
Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients
Date:1/22/2013

SCOTTSDALE, Ariz., Jan. 22, 2013 /PRNewswire-USNewswire/ -- A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment.

(Photo: http://photos.prnewswire.com/prnh/20120201/DC45876)

The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was led by physicians from Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).

Their findings show that Abraxane plus gemcitabine was well tolerated and resulted in clinically meaningful outcomes compared to gemcitabine alone, the current standard of care. The study abstract was released today and the data will be presented at the American Society of Clinical Oncology (ASCO) 2013 Gastrointestinal Cancers annual meeting in San Francisco on January 25th.

"We are ecstatic that this clinical trial of Abraxane plus gemcitabine improves survival for patients with advanced stage IV pancreatic cancer," said Dr. Daniel Von Hoff , international lead investigator for MPACT, chief scientific officer for Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, and TGen's Physician-In-Chief. "It once again demonstrates that laboratory science-based medicine can make a difference for patients."

MPACT is the largest phase III clinical trial completed in advanced pancreatic cancer with more than 800 patients. Findings from the study showed a 59 percent increase in one-year median survival rates from less than a quarter of the patients (22 percent) t
'/>"/>

SOURCE Scottsdale Healthcare
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
2. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
3. Sentara Healthcare, MDLIVE Forge Unique Equity Partnership in Virtual Medicine
4. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
5. BioDelivery Sciences Announces Completion of BNX Safety Study
6. Harris Poll Study Links Emotional Connection to Physicians Trust in Pharmaceutical Products
7. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
8. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
9. New Study Shows Promise For Women Needing Mesh-Augmented Pelvic Organ Prolapse (POP) Repair
10. BodyMedia Collaborates on Federal Health Research Study
11. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  AbbVie (NYSE: ABBV ... 3 clinical study called SONAR (Study Of Diabetic ... the investigational compound atrasentan - when added to standard ... patients with stage 2 to 4 chronic kidney ... a large, multinational, double-blind, placebo-controlled clinical study that ...
(Date:5/19/2013)... 20, 2013 Claret Medical, Inc. announced the publication ... Mieghem et al., Histopathology of Embolic Debris ... print in Circulation, May 7 th this research is ... Rotterdam, the Netherlands and the pathology team ... Cardiovascular Pathology Institute, Gaithersburg, Maryland.  This is ...
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy exams ... considered the most sensitive method for detecting colorectal cancers ... preventing cancer cases 3 . EndoChoice ® Inc. ... system significantly improves the accuracy of this procedure and ... EndoChoice will be discussing these clinical trial results and ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3
... , July 19, 2010 Today, Novo Nordisk announced the,landmark recruitment of ... effects of modern insulins in,the management of type 2 diabetes.[1] , ... Spanning 28 countries across 4 continents and involving ... therapy. , , , ...
... Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are ... Focused Ultrasound, scheduled for October 17 through 20 near ... , , ... edge preclinical, translational and clinical research related to one of today,s ...
Cached Medicine Technology:World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3MR-Guided Focused Ultrasound Symposium Announces Sponsors 2MR-Guided Focused Ultrasound Symposium Announces Sponsors 3
(Date:5/21/2013)... Limited mobility affects people in ways that the ... difficult to walk around, but everyday tasks like getting up ... of medical products made to assist those who need a ... seat. , Raised toilet seats keep users further ... or sit down. They come in a variety of sizes ...
(Date:5/20/2013)... Heritage Woods of Gurnee , ... Illinois, is hosting Breakfast and Bingo at 8:30 a.m. ... located at 3775 Grand Ave. in Gurnee, Illinois, serves ... who need some help to maintain their independence. , ... of bingo," says Tammy Temaner-Rosas, Director of Marketing for ...
(Date:5/20/2013)... When a shopper decides to buy a mattress ... process. Much of the stress and concern people express with ... to expect. Best Mattress Online, a blog about mattress ... their purchase proves smooth. , In the article, titled “ ... readers find helpful tips divided into two sections, questions to ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to treat ... as if not treated, it may involve the ureter and ... urinary tract infection in itself is not life threatening, if ... pyelonephritis. Women seem to have many more urinary tract infections ... as women after the age of fifty. , As ...
(Date:5/20/2013)... 2013 Eben Pagan's Accelerate ... public creating a frenzy among business owners and ... business training. WealthSpringMarketing.com's Tiffany Hendricks has published a ... exclusive bonus. , "Eben Pagan is a world ... to individuals serious about success," reports Hendricks. "Prior ...
Breaking Medicine News(10 mins):Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2
... ... 2009CLEVE to get their $54 marrow cheek-swab kit at no cost. , ... (Vocus) June 15, 2009 -- Two-year-old Eve is one of ... but so far her family has been unable to find one. Thanks to the Gift ...
... NATICK, Mass., June 15 Boston Scientific Corporation (NYSE: ... nine studies involving the Company,s Urology/Gynecology products will be ... Urogynecological Association (IUGA). Presentations will feature Boston Scientific,s ... to treat pelvic floor prolapse and stress urinary incontinence ...
... Unique Intelligent Order Routing allows hospital pharmacies to design ... levels , , ROSEMONT, Ill., June 15 ... Omnicell, Inc., (Nasdaq: OMCL ) a leading ... announced the Omnicell WorkflowRx (TM) 6.0 ...
... Early results from the second series of trials have ... a 4.4 log reduction (99.994%) in Methicillin Resistant Staph Aureus ... medical treatment facilities world wide with the spread of MRSA ... CDC reported (JAMA 2007) that MRSA alone is now associated ...
... considering hair replacement surgery is certain to have lots of questions ... it is called "surgery" causes a person to wonder, "Is Hair ... questions that we have regarding hair replacement ," ... explains, "People want to know that they are going to be ...
... Products announced today the first commercial, plant-based diamine oxidase (DAO). ... reports that this new diamine oxidase is orders of magnitude ... enzyme is available as a lyophilized powder. Price will be ... for test assays to detect spoilage by the presence of ...
Cached Medicine News:Health News:Cleveland Residents Lining up to Help Save a Life with Free Donor Kits 2Health News:Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 2Health News:Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 3Health News:Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 4Health News:Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 5Health News:Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 6Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 2Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 3Health News:Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts 2Health News:USHairReplacement.com Provides Wealth of Knowledge to Common Hair Replacement Questions 2
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer...
Conversion Kits For Modular Incubator Chamber...
... The AutoIncubator 96 can incubate and shake ... prepare 96 samples at a time. This ... and enzyme reactions, such as Proteinase K digestion. ... extraction process by preparing your samples with our ...
Inquire...
Medicine Products: